Should you buy Stem stock now?
No, the technical signal for Stem is currently SELL. Stem trades at $5.99 as of 8/6/2026. The overall technical signal is: Strong Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -0.515 with rising momentum (signal: -0.594); RSI is at 41.6 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $10.33 points to 72.5% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Stem stock?
The average analyst price target for Stem is $10.33. The current price is $5.99, which gives an upside of 72.5%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $9.30 and $11.36.
Is Stem a dividend stock?
No, Stem does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Stem stock?
Stem is rated as a stock with extreme risk. the annual standard deviation is 98.1%, which classifies the stock as extreme risk.
Is Stem overvalued?
No, Stem is considered undervalued based on the analyst price target (72.5% upside). Stem has the following valuation ratios: a P/S ratio of 0.4, a P/B ratio of 0.6. The analyst price target suggests that the stock is undervalued by 72.5%.
Is Stem overbought?
No, Stem is not overbought. RSI is at 41.6 (neutral zone). The technical indicators show: RSI is at 41.6 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 0.2% below the 20-day average (short-term downtrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Stem earnings report?
Stem reports its next earnings on August 12, 2026. The stock currently trades at $5.99.
Is Stem shorted?
Yes, Stem is shorted with 13.0% of the free float sold short. This is a very high level of short selling, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains. Data is updated daily based on official filings with the SEC.
Are insiders buying Stem stock?
Yes, insiders are net buyers of Stem – they are buying more shares than they are selling. Over the last 3 months, insiders have made 5 purchases and 5 sales. On a net basis, 156,288 $ worth of shares were bought. Across the last 20 reported transactions, the split is 5 purchases and 15 sales, with a net 48,598 $ sold. Active buyers include Musfeldt Brian, Tappin Matthew, Narayanan Arun and others. Insider buying is generally seen as a positive signal, because management is putting its own money into the company.
Is Stem a good stock?
Based on our total score, Stem is rated as a good stock with a total score of 61 out of 100. The stock scores above average on value, quality and momentum – it is among the top 39% in our database. The score is made up of Value: 98/100, Quality: 82/100, Momentum: 2/100. In addition: analysts see 72.5% upside to the price target; technical signal: Strong Sell. Whether Stem is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Stem stock?
The outlook for Stem based on current data: the average analyst price target is $10.33 (+72.5%); the stock is in a downtrend (below SMA50 and SMA200); the next earnings report is due on 8/12/2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Stem stock moving?
Stem is stable right now. The technical indicators show: the price is close to the 20-day average; short interest is 13.0% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Stem go?
The average analyst price target for Stem is $10.33, which corresponds to a potential gain of 72.5% from the current price of $5.99. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Stem fall?
We lack enough history to give a specific floor for Stem. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Stem do?
Stem.us udvikler software, der bruger kunstig intelligens til at styre ren energi. De tjener penge på at hjælpe kunderne med at planlægge, installere og drive deres energianlæg i USA og internationalt. Stem sælger både software og selve energilagringssystemerne, de såkaldte OE... The company belongs to the Forsyning sector, more specifically the Utilities - Renewable industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Stem as an investment.
Did Stem raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Stem. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Stem making money or losing money?
Yes, Stem is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 94.2% — which is excellent. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Stem go bankrupt?
The bankruptcy risk of Stem is rated as elevated. Altman Z2 (a model for assessing financial distress) is -14.23 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 5 — which is average. Debt relative to equity is 1,000% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Stem have a lot of debt?
Yes, Stem has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 1,000%. For the forsyning sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
